BioSpace News Archive

Feb. 21, 2020 13:00 UTC BOSTON--( BUSINESS WIRE )-- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present the edasalonexent program in Phase 3 development for the treatment of Duchenne muscular dystrophy at the XVIII International Conference on Duchenne and Becker Muscular Dystrophy, organized by Parent Project, in Rome, Italy. Joanne M. Donovan, M.D., Ph.D., Chief Medical Officer of Catabasis Pharmac

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Tom Kassberg, the company’s Chief Business Officer, will present at the SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at 11:00 AM ET in New York, NY.

Following are the latest Coronavirus news releases and story ideas for reporters, bloggers and media outlets.

Leading telehealth provider TeleDaddy has received LegitScript’s Stamp of Approval.

Intra-Cellular Therapies, Inc. announced the grant to four new employees of inducement stock options to purchase an aggregate of 6,688 shares of its common stock and restricted stock units for an aggregate of 6,681 shares of its common stock under its 2019 Inducement Award Plan.

The U.S. Food and Drug Administration authorized marketing of the first test to detect a genetic condition known as Fragile X Syndrome, the most common known cause of inherited developmental delay and intellectual disability.

Methodist Le Bonheur Healthcare recently launched Welcome Bluff City Baby, a pilot program designed to encourage reading and literacy interaction from birth.

New indication reflects distinct patient population in the REWIND study, including primarily people with multiple cardiovascular risk factors but without established cardiovascular disease

On February 7, 2020, the Government of Canada repatriated individuals and their families from Wuhan, China, which is the epicentre of the outbreak of novel coronavirus.

AdaptHealth Corp., the third largest provider of home medical equipment in the United States, announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019 before the opening of the financial markets on Tuesday, February 25, 2020.